ACEBUTOLOL HYDROCHLORIDE (acebutolol hydrochloride) by ANI Pharmaceuticals is clinical pharmacology acebutolol is a cardioselective, β-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (isa) in its therapeutically effective dose range. Approved for hypertension in adults, the management of ventricular premature beats, hypertension and 1 more indications. First approved in 1995.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Acebutolol is a cardioselective, β-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically effective dose range. Pharmacodynamics β1-cardioselectivity has been demonstrated in experimental animal studies. In…
Worked on ACEBUTOLOL HYDROCHLORIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.